{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:40Z","timestamp":1747181140265,"version":"3.40.5"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Cardiotoxicity is an important side effect of vascular endothelial growth factor inhibitors therapy in the treatment of cancer. Massive studies have shown bevacizumab-related hypertension, venous, and arterial thrombosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 56-year-old female patient was treated with bevacizumab monotherapy for lung adenocarcinoma. The patient was detected a poor R-wave increase with slight ST segment elevation in V1\u2013V3 leads, and ventricular arrhythmia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The incidental arrhythmia caused by bevacizumab was considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patients received aspirin and amiodarone (0.2\u2009g tid) to treat arrhythmia. After consultation with the cardiology department, the patient received a diagnostic coronary angiography. Coronary angiography showed 30% of the right coronary artery stenoses and no obvious organic stenosis in the left main artery, left anterior ascending, or left circumflex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient exhibited disappearance of chest tightness and rapid heartbeat after the treatment of amiodarone. Electrocardiogram monitoring results returning to normal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This is the first reported case of bevacizumab-associated arrhythmia. It is advisable to consider the risk of arrhythmia in bevacizumab monotherapy or combines treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034799","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:00:07Z","timestamp":1693602007000},"page":"e34799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0910-8731","authenticated-orcid":false,"given":"Yuanyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin(R)) in cancer treatment: a review of 15 years of clinical experience and future outlook.","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"109895","DOI":"10.1016\/j.intimp.2023.109895","article-title":"The mechanism and treatment of targeted anti-tumour drugs induced cardiotoxicity.","volume":"117","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R3-20250504","first-page":"10","article-title":"Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center.","volume":"7","author":"Waheed","year":"2021","journal-title":"Cardiooncology"},{"key":"R4-20250504","first-page":"1132","article-title":"Cardiotoxicity of chemotherapy and targeted agents.","volume":"11","author":"Mudd","year":"2021","journal-title":"Am J Cancer Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/jcm9082664","article-title":"Factors associated with adverse cardiovascular events in cancer patients treated with bevacizumab.","volume":"9","author":"Ngo","year":"2020","journal-title":"J Clin Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clgc.2012.12.002","article-title":"A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinoma.","volume":"11","author":"Harshman","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4330\/wjc.v6.i10.1067","article-title":"ST-segment elevation: distinguishing ST elevation myocardial infarction from ST elevation secondary to nonischemic etiologies.","volume":"6","author":"Deshpande","year":"2014","journal-title":"World J Cardiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1542-474X.2005.05588.x","article-title":"ECG repolarization waves: their genesis and clinical implications.","volume":"10","author":"Hlaing","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:10:13Z","timestamp":1746324613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":8,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034799","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}